Search For "clinical trials"
Research: Cancer drug could be used against malaria
Updated : 3 years, 4 months ago IST
A cancer drug currently in clinical trials has shown the potential to protect from, cure, and prevent transmission of malaria.
Read More
New drug found effective for treating complicated urinary tract infections
Updated : 3 years, 4 months ago IST
A combination of the drugs cefepime and enmetazobactam was more effective in treating both complicated urinary tract infections and acute pyelonephritis (AP), a bacterial infection causing kidney inflammation, than a standard treatment combining piperacillin and tazobactam.
Read More
Research: SARS-CoV-2 antigen levels linked to patient outcomes
Updated : 3 years, 6 months ago IST
Maryland [US], August 30 (ANI): According to a recent study published in the Annals of Internal Medicine, the amount of SARS-CoV-2 antigen detected in the blood of patients hospitalized with COVID-19 is related to the severity of the illness and other clinical outcomes.
Read More
New novel curative treatment for paediatric neuroblastoma patients
Updated : 3 years, 6 months ago IST
Washington [US], August 23 (ANI): Children who suffer a relapse of aggressive cancer known as neuroblastoma have small chances of survival. However, researchers have now shown that DHODH blockers, which are well-tolerated in humans, can cure neuroblastoma in mice if administered in combinati
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Study suggests improving critical illness communication for advanced cance
Updated : 3 years, 7 months ago IST
Lebanon [US], July 21 (ANI): By focusing on critical illness dialogues between patients with advanced cancer and their doctors, a quality improvement effort at the Dartmouth Cancer Center has increased these crucial communications by 70 per cent.
Read More
Covaxin booster dose increases immune response by 40 times, gives long-ter
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both
Read More
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Indian Industrial Hemp Association (IIHA) and Auriga Research Private Limi
Updated : 3 years, 8 months ago IST
New Delhi [India], June 20 (ANI/SRV): IIHA signed a MoU with India's leading testing, inspection, certification and clinical research organization Auriga Research Private Limited at their HQ in New Delhi, India.
Read More
Medical Expo India 2022, a massive show on medical equipment and lab devic
Updated : 3 years, 9 months ago IST
Kolkata (West Bengal) [India], June 14 (ANI/BusinessWire India): The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well as private players. Healthcare comprises hospitals, medical devices, clinical tria
Read More
New study challenges previous link between diabetes medication and fractur
Updated : 3 years, 9 months ago IST
Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose reabsorption, may help control blood sugar and protect kidney health in patients with diabetic renal failure; however, several large clinical trials have linked these drugs to a higher
Read More
FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says
Updated : 3 years, 9 months ago IST
Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).
Read More